Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors.

CNS Drugs
Marco Mula, M R Trimble

Abstract

Cognitive dysfunction is frequently observed in patients with epilepsy and represents an important challenge in the management of patients with this disorder. In this respect, the relative contribution of antiepileptic drugs (AEDs) is of relevance. The fact that a considerable number of patients require AED therapy for many years, or perhaps even a lifetime, emphasizes the need to focus on the long-term adverse effects of these drugs on cognition. The most prevalent of the CNS adverse effects observed during AED therapy are sedation, somnolence, distractibility, insomnia and dizziness. Sedation, in particular, is associated with most of the commonly used AED therapies. Nevertheless, cognitive function in individuals with epilepsy may also be influenced by several factors, of which AEDs constitute only one of many putative causes. In general terms, most studies agree that some differences exist among the older AEDs with regard to the effects on cognition, and some newer generation molecules may have a better cognitive profile than older AEDs. The mechanisms of action are an obvious determinant; however, there is still a lack of evidence for differentiation between available drugs with regard to cognitive effects. Some authors ha...Continue Reading

References

Dec 1, 1978·Epilepsia·C B Dodrill
May 1, 1975·Journal of the American Geriatrics Society·W L Smith, J B Lowrey
Jan 1, 1992·Epilepsia·D Lindhout, J G Omtzigt
Jun 1, 1991·Developmental Medicine and Child Neurology·I ForsytheR McGuire
Jan 1, 1991·Neurology·C B Dodrill, A S Troupin
Jun 1, 1990·Acta Neurologica Scandinavica·E P CalandreJ A Molina-Font
Mar 1, 1990·Neurology·K J MeadorD W King
Apr 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·A TartaraE Perucca
Jan 1, 1989·British Journal of Clinical Pharmacology·C Remy, D Beaumont
Jan 1, 1987·Epilepsia·S BerentB Abou-Khalil
Jul 28, 1984·Lancet·E H ReynoldsB K Toone
Dec 1, 1981·British Journal of Clinical Pharmacology·P J Thompson, M R Trimble
Oct 1, 1982·Epilepsia·P J Thompson, M R Trimble
Sep 1, 1981·The British Journal of Clinical Psychology·P ThompsonM Trimble
Oct 1, 1981·Journal of Clinical Neuropsychology·M SeidenbergT J Boll
Jul 1, 1995·Acta Neurologica Scandinavica·A SabersB B Lyon
May 1, 1995·Progress in Neuro-psychopharmacology & Biological Psychiatry·L G NeyensA P Aldenkamp
Mar 1, 1994·Seizure : the Journal of the British Epilepsy Association·S SveinbjornsdottirJ S Duncan
Dec 1, 1993·Journal of Neurology, Neurosurgery, and Psychiatry·R A GillhamM J Brodie
Sep 1, 1995·Neuropsychology Review·R J McCaffrey, H J Westervelt
Nov 1, 1996·Epilepsy Research·R KälviäinenP J Riekkinen
Apr 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·J P LeachM J Brodie
Apr 1, 1997·Epilepsy Research·L A Burton, C Harden
Jul 1, 1997·Brain & Development·N Gordon
Nov 19, 1997·The Journal of International Medical Research·F MonacoS Vighetti
May 13, 1998·Epilepsia·C B DodrillK W Sommerville

❮ Previous
Next ❯

Citations

Dec 25, 2009·Journal of Neurology·Joanne R FestaRonald M Lazar
May 24, 2013·Drug Design, Development and Therapy·Marco Mula
Dec 3, 2014·Epilepsy & Behavior : E&B·Christoph Helmstaedter, Juri-Alexander Witt
Feb 22, 2014·Current Opinion in Neurology·Kees P J Braun, Dieter Schmidt
Mar 25, 2011·Future Medicinal Chemistry·Marco Mula
Jun 19, 2014·Epilepsy Currents·Rochelle Caplan
Sep 12, 2012·Nature Reviews. Neurology·Laetitia PadovaniXavier Muracciole
Feb 7, 2016·Epilepsy & Behavior : E&B·Kristin Å AlfstadMorten I Lossius
Jun 2, 2012·Expert Review of Neurotherapeutics·Marco Mula
Feb 16, 2012·Expert Opinion on Drug Metabolism & Toxicology·Jose de LeonEdoardo Spina
Nov 28, 2012·Expert Opinion on Emerging Drugs·Marco Mula
Jan 24, 2016·Neurotoxicology·Wilmar SaldarriagaFlora Tassone
Feb 26, 2013·Brain & Development·Monique M J Van Schooneveld, Kees P J Braun
Jan 13, 2016·Acta Neurologica Scandinavica·M MulaN Agrawal
Jun 1, 2011·Epilepsy & Behavior : E&B·Ada PiazziniMonica Ferraroni
Oct 5, 2010·Epilepsy & Behavior : E&B·James W McAuleyBassel F Shneker
Feb 2, 2010·Epilepsy & Behavior : E&B·Kathryn M HumIrene M Elliott
Jan 16, 2010·Biological Psychiatry·Carmelo SgobioPaolo Calabresi
Oct 20, 2015·CNS Oncology·Melissa KerkhofCharles J Vecht
Aug 13, 2015·Epilepsy & Behavior : E&B·Ivan RektorAmos D Korczyn
Aug 25, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Juri-Alexander WittChristoph Helmstaedter
Nov 5, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M Mula, H R Cock
Apr 23, 2015·Annals of Neurology·Kim BoshuisenUNKNOWN TimeToStop cognitive outcome study group
Aug 28, 2009·Seizure : the Journal of the British Epilepsy Association·Hsiang-Yu YuDer-Jen Yen
Apr 30, 2014·Seizure : the Journal of the British Epilepsy Association·Gabriela PappStefan Evers
Sep 21, 2013·Epilepsy Research·Monique M J van SchooneveldKees P J Braun
Aug 24, 2013·Epilepsy & Behavior : E&B·Juri-Alexander WittChristoph Helmstaedter
Oct 25, 2011·Epilepsy & Behavior : E&B·Helena GauffinAnne-Marie Landtblom
Jun 12, 2013·Epilepsy & Behavior : E&B·Sabine HellwigLudger Tebartz van Elst
May 5, 2016·Annals of Anatomy = Anatomischer Anzeiger : Official Organ of the Anatomische Gesellschaft·Jariya Umka WelbatPeter Wigmore
Oct 6, 2016·BJPsych Open·Marco Mula, Josemir W Sander
Oct 22, 2016·NeuroImage. Clinical·Britta Wandschneider, Matthias J Koepp
Oct 1, 2016·Expert Review of Neurotherapeutics·Filippo Sean GiorgiGaetano Zaccara
Oct 17, 2016·Epilepsy & Behavior : E&B·Tamar M van VeenendaalJacobus F A Jansen
May 31, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·J StrettonJ Foong
Sep 25, 2016·Journal of Child Neurology·Azza M OrabyAdel F Hashish

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.